97 |
The Whole Truth on Incomplete Apposition with DES: Observations from Studies with Silolimus, Paclitaxel and Beyond |
Gary S. Mintz |
Jan. 14. 05 |
96 |
PPAR-r Agonist and In-stent Restenosis |
Yangsoo Jang |
Jan. 14. 05 |
95 |
FIM Results with a PC-coated Angiopeptin-Eluting Stent: Angiographic and IVUS Results |
Vincent On-Hing Kwok |
Jan. 14. 05 |
94 |
Drug-Eluting Stenting: Update on ABT 578(PREFER, and ENDEAVOR-I) |
Ian T. Meredith |
Jan. 07. 05 |
93 |
New Drug-Eluting Stent Trials: EASTER, IMPACT, PISCES, BioRest, and More |
Alexandre Abizaid |
Jan. 07. 05 |
92 |
Long Cypher Multicenter Registry Study |
Seung-Jung Park |
Jan. 07. 05 |
91 |
Debulking of Chronic Total Occlusions with Rotational or Directional Atherectomy before Stenting Trial: A Multicenter Randomized Study (DOCTORS) |
Etsuo Tsuchikane |
Dec. 31. 04 |
90 |
Role of MSCT in the Evaluation of Coronary Revascularization |
Yean-Leng Lim |
Dec. 31. 04 |
89 |
Percutaneous Treatment of Abdominal Aortic Aneurysms |
Richard R. Heuser |
Dec. 24. 04 |
88 |
Chronic Total Occlusion |
Barry D. Rutherford |
Dec. 24. 04 |